Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
SOT101 + Pembrolizumab for Advanced Cancers
Recruiting1 awardPhase 2
Whittier, California
This trial is testing a new drug called nanrilkefusp alfa together with an existing cancer treatment called pembrolizumab. Pembrolizumab is already approved for various cancer treatments and is often used with other therapies to improve survival rates. The goal is to see if combining these drugs can more effectively shrink tumors by boosting the immune system's ability to fight cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service